Project Grant R01AI198604
Award Date 6/4/26
Completion Date 5/31/31
Dollars Obligated $750K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
- Federal Project Grant Award Summary Tufts University School of Medicine received a $453,750 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2027. The grant funds research to investigate mechanisms by which bacteriophages evade cyclic oligonucleotide-based antiviral defense systems in bacteria, with specific focus on how phage proteins antagonize...
- FEDERAL GRANT AWARD SUMMARY The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida a Project Grant totaling $741,023 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective June 1, 2026, through May 31, 2031. The award funds development of VIGOR (Vibrio Infection Genomics for Outbreak Risk Forecasting), a satellite-based public health forecasting system designed to identify and monitor high-risk zones for pathogenic Vibrio...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $137,064 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 25, 2025. The two-year project, concluding June 30, 2027, delivers novel conceptual frameworks and computational models to measure and validate dynamic accessibility to healthcare using system science approaches. The primary...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $395,692 to the University of California, San Diego under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 17, 2025, for a project entitled "Enhancing Bacteriophage Function with Coevolution and Synthetic Biology." The award supports a five-year research initiative (through June 30, 2030) focused on identifying genetic modifications in bacteriophages that...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida a $1,348,845 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective February 13, 2026, with completion targeted for January 31, 2031. This research initiative investigates potassium (K+) channel regulation of antiviral immune responses, specifically examining how ATP-gated inward rectifier potassium (KATP) channels modulate...
- Federal Project Grant Award Summary The University of South Florida received a $470,953 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2030. This five-year research initiative will produce biomedical research and scientific knowledge concerning the role of SSR42, a regulatory RNA molecule, in virulence factor regulation and pathogenic...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Florida a Project Grant of $3.39 million under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on ATPase chromatin remodeling complexes as modulators of Human Immunodeficiency Virus (HIV-1) latency and therapeutic targets. The award, effective June 18, 2026, through May 31, 2030, supports research conducted at the university's...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $109,476 to the University of Wisconsin-Madison under the Allergy and Infectious Diseases Research program (CFDA 93.855) on November 30, 2025, with a completion date of May 31, 2027. This Project Grant supports fundamental research to understand the molecular mechanisms governing drug efflux in bacterial multidrug resistance transporters, specifically the NorA pump. The research...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Maryland, College Park a Project Grant totaling $571,412 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 11, 2026, with a completion date of May 31, 2031. This five-year research project investigates the role of linear diribonucleotides as signaling molecules in bacterial physiology and pathogenesis. The research builds upon prior findings...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $422,125 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 3, 2026, with completion targeted for January 31, 2028. This proof-of-concept study will develop, validate, and field-test wastewater-based epidemiology (WBE) methods using digital polymerase chain reaction (PCR)...